- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-20-0024987

About Trikona Pharmaceuticals Private Limited
Data last updated:
Trikona Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2016PTC102838. Its GSTIN is 36AAFCT6147H1Z5 (Telangana).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.65 Cr. It is led by directors Sura Surendranath Reddy and Sunil Kondapally Chandra.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H No.7 – 1 – 58 Amrutha Business Complex 04th Floor Opp Lal Bunglow Ameerpet, Hyderabad, Telangana, India – 500016.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.77 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹1.34 Cr (net margin 6.1%) and EBITDA of ₹1.91 Cr (EBITDA margin 8.8%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years and 65% over five years.
The company has about 183 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Trikona Pharmaceuticals. As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹2.8 Cr on record. The company has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in February 2022. Its 4 peer companies in the Pharma industry (Contract Research, Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 1 smaller; the largest is Sgpharma Private Limited with revenue of ₹21.85 Cr.
Trikona Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0024987). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website trikonapharma.com.
Company details
Recognitions & Rankings of Trikona Pharmaceuticals
Contact details
Trikona Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is trikonapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH No.7 – 1 – 58 Amrutha Business Complex 04th Floor Opp Lal Bunglow Ameerpet, Hyderabad, Telangana, India – 500016
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
To see the full contact details of Trikona Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Trikona Pharmaceuticals operates one associated brand: Trikona Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Innovates and produces pharmaceutical products for global health needs. | trikonapharma.com |
Business activity
The main business activity of Trikona Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Trikona Pharmaceuticals Private Limited, buy the company report.
Financials of Trikona Pharmaceuticals Private Limited
FY 2024 filings availableTrikona Pharmaceuticals Private Limited reported revenue of ₹21.77 Cr (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 65% over five years, including 14% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.91 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.34 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.8% | ||||
| Net Profit Margin | 6.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Trikona Pharmaceuticals Private Limited, buy the company report.
Board of directors of Trikona Pharmaceuticals Private Limited
Trikona Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sura Surendranath Reddy Also directs: VDC Diagnostics (Karnataka) LLP, Medinova Millennium Mri Services LLP, S Square Properties LLP and 5 more | Director | 21 Jan 2016 | 10 Years 9 Months | Current |
| Sunil Kondapally Chandra Also directs: VDC Diagnostics (Karnataka) LLP, S Square Properties LLP, Trikona Holdings LLP and 5 more | Director | 21 Jan 2016 | 10 Years 9 Months | Current |
Peer comparison
Trikona Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Contract Research, Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sgpharma Private Limited | ₹21.85 Cr (FY 2025) | 70.0% | Mumbai, Maharashtra, India | |||
| Anabiosis Medsciences Private Limited | ₹21.84 Cr (FY 2025) | -1.0% | Sampa, Gujarat, India | |||
| Jayanth Life Sciences Private Limited | ₹21.83 Cr (FY 2025) | 11.0% | Hyderabad, Telangana, India | |||
| Trikona Pharmaceuticals Private Limitedthis company | ₹21.77 Cr (FY 2025) | ₹1.34 Cr | 6.1% | 14.0% | 183 | Hyderabad, Telangana, India |
| Shivek Labs Limited | ₹21.54 Cr (FY 2017) | -53.0% | Chandigarh, India |
To see the full peer comparison of Trikona Pharmaceuticals Private Limited, buy the company report.
Auditor
Trikona Pharmaceuticals Private Limited is audited by M. Anandam & Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M. Anandam & Co | FY 2024 | 000125S |
Shareholding
The shareholding of Trikona Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Trikona Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Oct 2025 | 101179375 | Hdfc Bank Limited | ₹2 Cr | Open | |
| 30 Sep 2024 | 100983407 | Idbi Bank Limited | ₹1.5 Cr | Satisfied | |
| 13 Dec 2016 | 100071348 | Idbi Bank Limited | ₹1.3 Cr | Satisfied |
To see the full charge records of Trikona Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Trikona Pharmaceuticals Private Limited has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in February 2022.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2022 | Rights issue | ₹2 Cr | Investors: an individual |
| Aug 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Oct 2017 | Rights issue | ₹7.64 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Trikona Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Trikona Pharmaceuticals Private Limited was last rated by Icra on 03 Jun 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 03 Jun 2021 |
To see the full credit ratings and regulatory alerts of Trikona Pharmaceuticals Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Trikona Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Trikona Pharmaceuticals Private Limited has a workforce of 183 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 183 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Trikona Pharmaceuticals Private Limited, buy the company report.
GST
Trikona Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCT6147H1Z5 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Trikona Pharmaceuticals Private Limited, buy the company report.
Recent activity
Trikona Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Sunil Kondapally Chandra was appointed as Director on 21 Jan 2016.
Frequently asked questions
Trikona Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 January 2016 (10+ years old) and is registered under CIN U24233TG2016PTC102838.
Trikona Pharmaceuticals has 2 current directors:
- Sura Surendranath Reddy - Director
- Sunil Kondapally Chandra - Director
The latest financial statements of Trikona Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Trikona Pharmaceuticals is 36AAFCT6147H1Z5, registered in Telangana.
The CIN (Corporate Identification Number) of Trikona Pharmaceuticals is U24233TG2016PTC102838. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Trikona Pharmaceuticals was incorporated on 21 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
Trikona Pharmaceuticals has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in February 2022.
The peers of Trikona Pharmaceuticals by revenue are Sgpharma Private Limited, Anabiosis Medsciences Private Limited, Jayanth Life Sciences Private Limited, Shivek Labs Limited, all in the Pharma industry (Contract Research, Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sunil Kondapally Chandra was appointed as Director on 21 Jan 2016. Sura Surendranath Reddy was appointed as Director on 21 Jan 2016.
Yes, Trikona Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0024987).
Trikona Pharmaceuticals can be reached through the website trikonapharma.com. Its registered office is in Hyderabad, Telangana, India.

